Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
aTyr Pharma, Inc. (ATYR) had Weighted-Average Shares Outstanding (Diluted) of 98.07M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-10.31M |
|
-- |
|
-- |
|
$10.88M |
|
$-10.88M |
|
$0.57M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.88M |
|
$-10.62M |
|
98.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
98.07M |
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$58.36M |
|
$4.13M |
|
$11.46M |
|
$69.83M |
|
$11.40M |
|
$0.04M |
|
$9.84M |
|
$21.23M |
|
$48.59M |
|
$48.59M |
|
$48.59M |
|
98.09M |
|
| Cash Flow Statement Financials | |
$-21.87M |
|
$26.82M |
|
$-0.27M |
|
$12.98M |
|
$17.66M |
|
$4.68M |
|
$2.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.12 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.22% |
|
-21.22% |
|
-14.77% |
|
-21.20% |
|
$0.50 |
|
$-0.23 |
|
$-0.22 |
|